Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
The latest annual World Preview 2018, Outlook to 2024 shows that orphan drugs are forecast to remain one of the fastest growth areas of the global pharmaceutical market. The rare disease space is predicted to capture 20% of the total $1.2trn market in 2024.
Supporting this growth are the launches of novel therapies, including gene and cell therapies, as well as increased access to medicines globally.